- Home
- ZLAB vs FULTP Comparison
ZLAB vs FULTP Comparison
Compare ZLAB & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | FULTP |
|---|---|---|
| Founded | 2013 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | N/A |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | FULTP |
|---|---|---|
| Price | $25.85 | $17.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $49.60 | N/A |
| AVG Volume (30 Days) | ★ 755.7K | 7.2K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | 32.48 |
| EPS | N/A | ★ 1.02 |
| Revenue | ★ $460,156,000.00 | $276,768,000.00 |
| Revenue This Year | $9.75 | N/A |
| Revenue Next Year | $26.03 | N/A |
| P/E Ratio | ★ N/A | $17.09 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $17.21 |
| 52 Week High | $34.72 | $20.32 |
Technical Indicators
Market Signals| Indicator | ZLAB | FULTP |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 38.10 |
| Support Level | $24.81 | $17.35 |
| Resistance Level | $27.20 | $18.01 |
| Average True Range (ATR) | 0.77 | 0.24 |
| MACD | -0.10 | -0.03 |
| Stochastic Oscillator | 69.71 | 24.64 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.